Heart Failure
Conditions
Interventions
Sponsors
Chinese Academy of Medical Sciences Fuwai Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 75 Years
Inclusion criteria
Inclusion criteria: 1. Aged 18 to 75 years; 2. Patients who meet the diagnostic criteria of Western medicine for coronary heart disease, elective patients within two weeks after DCB surgery; 3. Voluntary selection of patients who undergo coronary angiography 12 months after surgery; 4. Meet the TCM criteria for syndrome differentiation of Qi deficiency and blood stasis (total score >=8 points, and secondary symptoms >= 4 points); 5. The subjects voluntarily participated in the trial and signed the informed consent.
Exclusion criteria
Exclusion criteria: 1. Heart valve disease, congenital heart disease, aortic dissection or aortic aneurysm requiring surgical or interventional treatment; 2. Hypertrophic obstructive cardiomyopathy, restrictive cardiomyopathy, active myocarditis, infective endocarditis, constrictive pericarditis or other pericardial diseases; 3. Patients with malignant arrhythmia and poorly controlled hypertension; 4. Cardiac synchronization therapy within 3 months; cardiac PCI, CABG and other major vascular surgery or acute coronary syndrome within 1 month; 5. Cerebrovascular events such as old stroke and transient cerebral ischemia occurred within 6 months; 6. Patients with serious primary diseases and dysfunctions of the lung, liver, kidney, hematopoietic system, immune system, etc.; 7. Subjects who participated in other drug clinical trials or interventional studies within the first four weeks of this trial; 8. Patients with serious primary diseases and dysfunctions of the lung, liver, kidney, hematopoietic system, immune system, etc.; 9. Subjects who participated in other drug clinical trials or interventional studies within the first four weeks of this trial; 10. Those who are deemed unsuitable to participate in clinical trials by the investigator.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| hospitalization for worsening heart failure; | — |
Secondary
| Measure | Time frame |
|---|---|
| all-cause mortality;hospitalization for cardiovascular events;NT-proBNP;New York Heart Association cardiac function;left ventricular ejection fraction;Six-Minute Walk Distance;Minnesota heart failure quality of life scale;Hospital Anxiety and Depression Scale;Quantization Table for Traditional Chinese Medicine Syndrome Differentiation;blood routine; | — |
Countries
China
Contacts
Public ContactMa Lihong
Chinese Academy of Medical Sciences Fuwai Hospital
Outcome results
None listed